Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI
Completed · Not applicable
Conditions studied: Influenza, Influenza A, Influenza B, COVID-19, Respiratory Syncytial Virus (RSV)
In brief
The goal of this prospective, digital randomized controlled trial is to evaluate the effectiveness of a predictive ILI detection algorithm and associated alerts during influenza season for adults living in the contigent United States. The main study objectives are to assess the effectiveness of predictive ILI detection algorithm and associated alerts on protective behaviors related to ILI and assess the accuracy of a predictive ILI detection algorithm using participant self-reported ILI symptoms and diagnosis.
Key facts
- Study ID
- NCT06229444
- Run by
- Evidation Health
- People needed
- 17043
- Starts
- 2024-02-12
- Expected to finish
- 2024-09-06
- Last updated by the study team
- 2024-09-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Member of the Evidation platform
- 18 years or older
- Lives in the U.S.
- Currently owns and uses a consumer wearable activity tracker (Apple Watch, Garmin, or Fitbit) linked to their Evidation account
- Meets data density requirements for wearable data: Steps and heart rate data present for 15% of the last 60 days (or no fewer than 2 total days for Evidation accounts less than 60 days old)
You may not qualify if…
- Does not have an Evidation account
- Not 18 years or older
- Does not live in the U.S.
- Does not have an activity tracker linked to their Evidation account
- Enrolled in an Evidation supported ILI monitoring and engagement program, or clinical study (e.g., FluSmart)
Where it is running
- Evidation Health — San Mateo, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.